Pathogenic Drivers of Difficult-to-Treat Rheumatoid Arthritis: Synovium and Beyond

András Miklós Dorgó1, Lilla Gunkl-Tóth1,2,3, György Nagy1,4,5

  • 1Department of Rheumatology and Immunology, Semmelweis University, 1023 Budapest, Hungary.

Insights

Difficult-to-treat rheumatoid arthritis (RA) involves complex factors beyond standard treatments. Understanding genetic, immune, and environmental influences is key to identifying new therapies for refractory RA.

Area of Science:

  • Rheumatology
  • Immunology
  • Genetics

Background:

  • Difficult-to-treat rheumatoid arthritis (D2T RA) presents persistent symptoms despite various therapies.
  • This condition poses a significant clinical challenge, impacting a substantial patient subset.

Purpose of the Study:

  • To provide a comprehensive review of molecular and cellular mechanisms underlying D2T RA.
  • To explore factors contributing to therapeutic resistance in rheumatoid arthritis.

Main Methods:

  • Narrative review synthesizing evidence on genetic, epigenetic, and immune factors.
  • Examination of synovial signatures, stromal cell pathways, and central determinants.
  • Inclusion of comorbid, environmental, and treatment-related factors.

Main Results:

  • D2T RA is influenced by a complex interplay of genetic, epigenetic, autoantibody, and immune cell factors.
  • Synovial and stromal cell pathways may drive chronicity independently of traditional targets.
  • Peripheral and central determinants, comorbidities, and environmental factors impact outcomes.

Conclusions:

  • A multifaceted approach is needed to understand and treat D2T RA.
  • Better patient stratification and novel therapeutic targets can be identified by integrating diverse biological and clinical data.
  • Addressing complex factors is crucial for managing refractory rheumatoid arthritis.

Related Concept Videos

T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
2.9K
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
647
Autoimmune Disorders01:29

Autoimmune Disorders

Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
2.0K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
13.4K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
658
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
16.0K